TREPONEMA PALLIDUM HEMAGGLUTINATION (TPHA)

The TREPONEMA PALLIDUM HEMAGGLUTINATION (TPHA) test detects antibodies specific to Treponema pallidum using a hemagglutination method on a blood sample to confirm exposure to syphilis. It is routinely used for sexual‑health screening, antenatal checks and post‑exposure testing and is offered with discreet, licensed home sample collection and fast, confidential electronic reporting across Dubai and the UAE. Because treponemal antibodies often remain positive after successful treatment, a reactive TPHA requires clinical correlation and usually follow‑up with non‑treponemal tests (eg, RPR/VDRL) and specialist consultation to determine active infection and guide management.

• Treponema pallidum Hemagglutination (TPHA) — Antibodies (qualitative)
• TPHA titer — Quantitative antibody titre (when requested)
• Result interpretation — Reactive / Non‑reactive
• Sample type — Venous blood (serum)
• Home sample collection by licensed phlebotomist across Dubai & UAE

• TPHA assay detecting treponemal antibodies for accurate syphilis screening and confirmation
• High sensitivity and specificity — commonly used to confirm reactive non‑treponemal tests (RPR/VDRL)
• Licensed phlebotomist home sample collection across Dubai and the UAE with discreet, clinic‑grade handling
• Fast, confidential digital results (typically 24–48 hours) with clear interpretation guidance
• Clinical note: TPHA can remain positive after successful treatment, so results require clinical correlation and possible follow‑up

• High‑specificity treponemal antibody test to detect exposure to Treponema pallidum
• Recommended as a confirmatory test alongside non‑treponemal screening (RPR/VDRL)
• Licensed, discreet home venous blood collection by certified phlebotomists across Dubai and the UAE
• Processed in UAE‑licensed laboratories with fast, confidential electronic results and clinician guidance
• Important: TPHA often remains positive after treatment and is not suitable for monitoring therapy response

• Serology assay detecting anti-Treponema pallidum antibodies (TPHA) for accurate syphilis screening and confirmation
• Licensed home phlebotomist collection across Dubai and the UAE with discreet, appointment-based sample pickup
• Fast, confidential electronic report—typically available within 24–48 hours—showing reactive or non-reactive results
• Clinical note: TPHA is a treponemal test that may remain positive after treatment; correlate with symptoms and non-treponemal tests (RPR/VDRL) for active infection